PPARG and obesity due to melanocortin 4 receptor deficiency: Taken the rosiglitazone-induced metabolic improvement and gene expression restoration together, our results suggest that increasing PPARγ transcriptional activity could overcome the HFD-induced obesity and adipocyte hypertrophy in PPARγ3RA/+ mice.